Page 28 - Delaware Business Times - DE222
P. 28
BIOPHARMACEUTICAL BUSINESS ORGANIZATIONS
Kris Vaddi
Prelude Therapeutics
Kris Vaddi spent 14 years at Incyte where he helped develop one of its most important drugs, Jakafi. After
two decades in the biopharmaceutical industry though, he wanted to return to the grassroots innovation of a startup, and left to found Prelude Therapeutics in 2016. The company has drawn increasing international attention for its work on small molecule inhibitors,
a developing therapy that is more targeted in approach with fewer side effects than traditional cancer therapies like chemotherapy or radiation. Prelude is working on treatments for blood, brain, and lymph node cancers. The promise of Prelude’s work drove it to become the newest publicly traded company to IPO from Delaware, raising hundreds of millions of dollars from investors since 2020, and it is now planning to open a new headquarters and research lab at the Chestnut Run Innovation & Science Park.
ALMA MATERS:
BOARDS:
Q&A:
Bob Chadwick
New Castle County Chamber of Commerce
Joining the New Castle County Chamber of Commerce in 2006, Robert “Bob” Chadwick has since served in a number of roles including director of the Economic Development Council, vice president for business and economic development and executive vice president before being chosen to
lead the chamber in 2017. The public relations veteran had spent time in the state and federal government, as well as with the former First USA Bank, before joining the chamber, and leaned on those skills to be an adept advocate for the businesses of Delaware’s largest county. Under Chadwick’s leadership, the NCCCC helped hundreds of member businesses navigate the pandemic, and has also grown its business incubator and accelerator, the Emerging Enterprise Center. He announced this year that he is retiring at the end of 2023.
Congratulations
HERVÉ HOPPENOT
on your Delaware Business Times Delaware 222 recognition.
26 DELAWARE 222 | DelawareBusinessTimes.com
